Search - tctmd.com

Displaying 161 - 180 of 262

Sort: Relevancy | Date

News Daily News

ACC/AHA Guideline Writers’ Disclosures vs Open Payments Don’t Add Up

Caitlin E. Cox

December 05, 2019

News Conference News VEITH 2019

Endovascular Office-Based Labs: Balancing Upsides Against Potential for Abuse

L.A. McKeown

November 28, 2019

News Conference News VEITH 2019

More Real-world Data Support Safety of Paclitaxel-Based Devices in PAD

L.A. McKeown

November 22, 2019

News Conference News VIVA 2019

Calcium Conundrum: New Scores, Research Aim to Boost Outcomes in PAD Interventions

L.A. McKeown

November 13, 2019

News Daily News

Disparate US Trends in Early CVD Deaths Speak to Need for Targeted Prevention

Caitlin E. Cox

October 21, 2019

News Daily News

FDA Gives Rivaroxaban Another VTE-Related Indication

Todd Neale

October 14, 2019

News Daily News

German Analysis Supports Long-term Safety of Paclitaxel-Based Therapies

L.A. McKeown

October 09, 2019

News Conference News TCT 2019

LEVANT: Patient-Level Data Show No Increase in 5-Year Death for Paclitaxel DCBs in PAD

L.A. McKeown

September 28, 2019

News Conference News TCT 2019

‘Spooky’ Signal Still Haunts Paclitaxel DCBs in PAD, but Updated Analysis Reassures

L.A. McKeown

September 28, 2019

Presentation TCT 2019

Safety of PTX Devices for PAD in Japan: Academic View

Presenter: Masato Nakamura

September 26, 2019

Presentation TCT 2019

Statistical Considerations: Competing Risk, Pooling Data, RCT vs. Observational Data

Presenter: Roseann White

September 26, 2019

Presentation TCT 2019

Moving From “Signal Detection” to “Signal Discernment”: An FDA View

Presenter: Eleni Whatley

September 26, 2019

News Daily News

Lifetime Risk of PAD Varies by Race, but All Are Vulnerable to Traditional Risk Factors

L.A. McKeown

September 16, 2019

News Daily News

TCTMD’s Top 10 Most Popular Stories for August 2019

Shelley Wood

August 30, 2019

News Daily News

FDA Gives Eagerly Awaited Update on Mortality With Paclitaxel-Coated Devices in PAD

Todd Neale

August 07, 2019

News Industry News

Boston Scientific Responds to the FDA’s Guidance on Use of Peripheral Paclitaxel Devices for Treatment of PAD

August 07, 2019

News Opinion Off Script

Off Script: Through ‘Paclitaxelgate,’ Some Upsides to Uncertainty

Sahil Parikh, MD

July 29, 2019

News Daily News

Smoking More Strongly Linked to Long-term Risks of PAD Than to Other Types of CVD

Todd Neale

July 24, 2019

News Daily News

Microvascular Disease Quadruples Risk of Leg Amputation

L.A. McKeown

July 08, 2019

News Daily News

FDA Panel Talks Labeling, Urges Cooperation for Paclitaxel Mortality Signal in PAD

L.A. McKeown

June 20, 2019

Advertisement

ACC/AHA Guideline Writers’ Disclosures vs Open Payments Don’t Add Up

Endovascular Office-Based Labs: Balancing Upsides Against Potential for Abuse

More Real-world Data Support Safety of Paclitaxel-Based Devices in PAD

Calcium Conundrum: New Scores, Research Aim to Boost Outcomes in PAD Interventions

Disparate US Trends in Early CVD Deaths Speak to Need for Targeted Prevention

FDA Gives Rivaroxaban Another VTE-Related Indication

German Analysis Supports Long-term Safety of Paclitaxel-Based Therapies

LEVANT: Patient-Level Data Show No Increase in 5-Year Death for Paclitaxel DCBs in PAD

‘Spooky’ Signal Still Haunts Paclitaxel DCBs in PAD, but Updated Analysis Reassures

Safety of PTX Devices for PAD in Japan: Academic View

Statistical Considerations: Competing Risk, Pooling Data, RCT vs. Observational Data

Moving From “Signal Detection” to “Signal Discernment”: An FDA View

Lifetime Risk of PAD Varies by Race, but All Are Vulnerable to Traditional Risk Factors

TCTMD’s Top 10 Most Popular Stories for August 2019

FDA Gives Eagerly Awaited Update on Mortality With Paclitaxel-Coated Devices in PAD

Boston Scientific Responds to the FDA’s Guidance on Use of Peripheral Paclitaxel Devices for Treatment of PAD

Off Script: Through ‘Paclitaxelgate,’ Some Upsides to Uncertainty

Smoking More Strongly Linked to Long-term Risks of PAD Than to Other Types of CVD

Microvascular Disease Quadruples Risk of Leg Amputation

FDA Panel Talks Labeling, Urges Cooperation for Paclitaxel Mortality Signal in PAD

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content